Vktx nasdaq.

Standing squarely in the bull camp, BTIG analyst Justin Zelin rates VKTX a Buy along with a $20 price target. This target puts the upside potential at a whopping 221%. This target puts the upside ...Shares of NASDAQ VKTX opened at $13.01 on Monday. Viking Therapeutics has a 12 month low of $3.54 and a 12 month high of $25.72. The stock has a 50 day moving average of $10.86 and a 200-day ...Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Find the latest Madrigal Pharmaceuticals, Inc. (MDGL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest on short interest for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.

Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Rhumbline Advisers acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to its most recent …

Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ...Dec 1, 2023 · Viking Therapeutics last announced its quarterly earnings data on October 25th, 2023. The biotechnology company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.01. Viking Therapeutics has generated ($0.93) earnings per share over the last year ( ($0.93) diluted earnings per share). He does not neglect the obesity-centered candidate VK2735, however, and writes, “We view VKTX’s lead candidate THR-β agonist VK2809 for NASH as similar to Madrigal Pharmaceutical’s MGL-3196 ...Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ETCompany Participants. Stephanie Diaz - Manager of Investor Relations. Brian Lian - Viking’s ...

Shares of NASDAQ VKTX opened at $13.01 on Monday. Viking Therapeutics has a 12 month low of $3.54 and a 12 month high of $25.72. The stock has a 50 day moving average of $10.86 and a 200-day ...

According to the issued ratings of 9 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 9 buy ratings for VKTX. The average twelve-month price prediction for Viking Therapeutics is $30.25 with a high price target of $37.00 and a low price target of $19.00.

Get the latest Madrigal Pharmaceuticals Inc (MDGL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Mar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of ...Fintel reports that on April 27, 2023, HC Wainwright & Co. maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 41.39% Upside. As of ...NAV / 1-Day Return 392.46 / 0.42 %. Total Assets 2.7 Bil. Adj. Expense Ratio 0.080%. Expense Ratio 0.080%. Distribution Fee Level Low. Share Class Type Institutional. Category Large Blend ...Viking Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VKTX updated stock price target summary.

Feb 9, 2023 · Viking Therapeutics, Inc. (NASDAQ:NASDAQ:VKTX) Q4 2022 Results Conference Call February 8, 2023 4:30 AM ETCompany ParticipantsStephanie Diaz - Investor... Fintel reports that on August 8, 2023, Stifel reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 142.45% Upside. As of August 2 ...VKTX Viking Therapeutics Inc Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share. All thanks to its potential treatment for obesity, VK2735. All thanks to its ...Based on analysts offering 12 month price targets for VKTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a good speculative biotech play to look into. That's because it just recently released positive results from its phase 2b VOYAGE study, ...VKTX: Viking Therapeutics broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. ... NASDAQ data is at least 15 minutes delayed.The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023. The analyst firm set a price target ...The Viking Therapeutics stock price gained 0.94% on the last trading day (Wednesday, 29th Nov 2023), rising from $11.72 to $11.83. During the last trading day the stock fluctuated 4.26% from a day low at $11.74 to a day high of $12.24. The price has been going up and down for this period, and there has been a 5.91% gain for the last 2 weeks.Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing treatments for liver diseases, post surgical complications, and other ailments. Despite a hefty short interest percentage, the firm's shares ...Oppenheimer analyst Jay Olson maintained a Buy rating on Viking Therapeutics ( VKTX – Research Report) yesterday and set a price target of $40.00. The company’s shares closed yesterday at $24. ...

Fintel reports that on April 27, 2023, HC Wainwright & Co. maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 41.39% Upside. As of ...

VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 12.28 ...

Viking Therapeutics (NASDAQ: VKTX) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. This data comes from its Phase 1 study of ...Viking Therapeutics, Inc. (NASDAQ:VKTX), based in San Diego, California, is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and ...VKTX Viking Therapeutics Inc Viking Therapeutics to Present at SVB Securities Global Biopharma ConferenceIn the last 3 months, 9 analysts have offered 12-month price targets for Viking Therapeutics. The company has an average price target of $33.0 with a high of $40.00 and a low of $24.00. Below is a ...Rhumbline Advisers acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to its most recent …Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Find the latest press releases from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Viking Therapeutics Inc (Symbol: VKTX), where a total of 11,518 contracts have traded ...Viking Therapeutics, Inc. (NASDAQ:VKTX) insiders who bought shares over the past year were rewarded handsomely last week.The stock rose 8.7%, resulting in a US$167m rise in the company's market ...Financial ratios and metrics for Viking Therapeutics, Inc. (VKTX). Includes annual, quarterly and trailing numbers with full history and charts. ... NASDAQ: VKTX · IEX Real-Time Price · USD. Add to Watchlist 12.37 +0.54 (4.56%) Nov 30, 2023, 12:09 PM EST - Market open. Overview; Financials; Statistics; Forecast; Dividends; Profile;

Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ... The Viking Therapeutics stock price gained 0.94% on the last trading day (Wednesday, 29th Nov 2023), rising from $11.72 to $11.83. During the last trading day the stock fluctuated 4.26% from a day low at $11.74 to a day high of $12.24. The price has been going up and down for this period, and there has been a 5.91% gain for the last 2 weeks.Please enter a valid Stock, ETF, Mutual Fund, or index symbol. Recent research: Viking Therapeutics Inc. Viking Therapeutics Inc VKTX:NASDAQ. Last Price ...VKTX Viking Therapeutics Inc Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021Instagram:https://instagram. mortgage company in texaspharmxhow many financial advisors in the uscost of postage stamp 2022 Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ... mortgage broker for self employed near meimcg etf Viking Therapeutics, Inc. (VKTX). NASDAQ: VKTX · IEX Real-Time Price · USD. nasdaq mbb VKTX (U.S.: Nasdaq) Overview Profile FinancialsMar 19, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 83% based on the firm’s underlying fundamentals and the stock ...